GENE ONLINE|News &
Opinion
Blog

Seres Therapeutics
Trials & Approvals Fecal Microbiota TransplantationFDA Approval
Nestle and Seres Land First-Ever Fecal Microbiota Product Approval From FDA
2023-04-27
Trials & Approvals Clostridium Difficile
Seres Therapeutics’ Microbiome Therapy for Recurrent C. difficile Infections, Shines in Phase 3
2020-08-12
LATEST
*Catharanthus roseus* Cells Show Varied Antioxidant Response to *Schizophyllum commune* Mycelium Extract Versus Filtered Culture Medium
2026-05-10
Faraday Future Appoints YT Jia as CEO, Jerry Wang as Executive Chairman
2026-05-10
Contagious Yawning May Start in the Womb, Study in *Current Biology* Reveals
2026-05-10
New Medication Combinations Show Promise for Treatment-Resistant Depression in *JAMA Psychiatry* Study
2026-05-10
Ellomay Capital Completes Sale of Dorad Energy Holdings on May 10, 2026
2026-05-10
Digitalis Glycosides Studied for Heart Failure Treatment at ESC Heart Failure 2026 Congress
2026-05-10
Digoxin Lowers Death Risk and Heart Failure in Rheumatic Heart Disease Patients, Study Finds
2026-05-10
READ MORE
EVENT
2026-05-11
ASGCT (Gene and Cell Therapy Advances)
Boston, Massachusetts
2026-05-29
ASCO 2026 (Major Oncology Clinical Data)
Chicago, Illinois
2026-06-22
BIO International Convention (Global Biotech Showcase)
Boston, Massachusetts
2026-06-25
Medical Taiwan 2026 (Devices, Diagnostics, Digital & Smart Health)
Taipei, Taiwan
2026-06-25
ASCO Breakthrough 2026 (Next-Gen Oncology Innovation)
Singapore
2026-07-08
ISSCR (Regenerative Medicine &Cell Therapy)
Montreal, Canada
SEE MORE
Scroll to Top